CADL
Price
$9.79
Change
+$0.32 (+3.38%)
Updated
Jun 26 closing price
Capitalization
717.32M
53 days until earnings call
Intraday BUY SELL Signals
SPRY
Price
$8.54
Change
+$0.52 (+6.48%)
Updated
Jun 26 closing price
Capitalization
839.11M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs SPRY

CADL vs SPRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CADL vs. SPRY commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and SPRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2026
Stock price -- (CADL: $9.79 vs. SPRY: $8.45)
Brand notoriety: CADL and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 223% vs. SPRY: 253%
Market capitalization -- CADL: $717.32M vs. SPRY: $839.11M
CADL [@Biotechnology] is valued at $717.32M. SPRY’s [@Biotechnology] market capitalization is $839.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, CADL is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 4 bearish.
  • SPRY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CADL is a better buy in the short-term than SPRY.

Price Growth

CADL (@Biotechnology) experienced а +17.81% price change this week, while SPRY (@Biotechnology) price change was -12.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +1916.03%.

Reported Earning Dates

CADL is expected to report earnings on Aug 19, 2026.

SPRY is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($839M) has a higher market cap than CADL($717M). CADL YTD gains are higher at: 73.274 vs. SPRY (-27.468). CADL has higher annual earnings (EBITDA): -50.3M vs. SPRY (-90.79M). SPRY has more cash in the bank: 288M vs. CADL (195M). CADL has less debt than SPRY: CADL (49.3M) vs SPRY (97.8M). SPRY has higher revenues than CADL: SPRY (143M) vs CADL (0).
CADLSPRYCADL / SPRY
Capitalization717M839M85%
EBITDA-50.3M-90.79M55%
Gain YTD73.274-27.468-267%
P/E RatioN/A151.25-
Revenue0143M-
Total Cash195M288M68%
Total Debt49.3M97.8M50%
TECHNICAL ANALYSIS
Technical Analysis
CADLSPRY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 25 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
SPRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEFRX32.580.22
+0.68%
First Eagle Rising Dividend Fund R6
MASKX32.520.03
+0.09%
iShares Russell 2000 Small-Cap Idx Instl
VIDGX12.04N/A
N/A
Vanguard International Dividend Gr Inv
OAKEX21.06-0.07
-0.33%
Oakmark International Small Cap Investor
RNWCX104.41-0.84
-0.80%
American Funds New World R3

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with AURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+3.38%
AURA - CADL
47%
Loosely correlated
+1.46%
RXRX - CADL
43%
Loosely correlated
+5.09%
NKTX - CADL
40%
Loosely correlated
+1.08%
BCYC - CADL
40%
Loosely correlated
+2.00%
XNCR - CADL
40%
Loosely correlated
+2.37%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+5.36%
LPCN - SPRY
63%
Loosely correlated
+3.78%
CGON - SPRY
35%
Loosely correlated
-1.36%
LXEO - SPRY
33%
Poorly correlated
+1.49%
ABEO - SPRY
32%
Poorly correlated
+0.90%
CADL - SPRY
31%
Poorly correlated
+3.38%
More